首页 > 最新文献

Maedica最新文献

英文 中文
Impact of the COVID-19 Pandemic on Brain Metastases in Breast Cancer Patients. COVID-19大流行对乳腺癌患者脑转移的影响
Pub Date : 2025-06-01 DOI: 10.26574/maedica.2025.20.2.250
Ruxandra Vatavu, Alexandru Misailoaie, Roxana Florentina Gavril, Codrin Gabriel Lucasievici, Anca Sava

Objectives: To evaluate the impact of the COVID-19 pandemic on the diagnosis and treatment delays of brain metastases secondary to breast cancer, and to compare patient demographics, disease characteristics and outcomes before and during the pandemic.

Materials and methods: A retrospective study was conducted on 100 patients who were surgically treated for brain metastases in the Neurosurgery Clinic of "Prof. Dr. Nicolae Oblu" Clinical Emergency Hospital, Iasi, Romania. Patients were divided into two groups: pre-pandemic (2018-2020, n=57) and pandemic (2020-2022, n=43). Clinicopathological data, including demographics, metastasis localization, number and duration, were collected and analyzed.

Results: The pandemic period saw a shift towards younger patients, with 51% younger than 55 years compared to an average age of 57.9 years before the pandemic. Metastases were mostly located in the parietal lobe (61%). Despite a balanced rural-urban patient distribution, diagnostic delays were observed, with an average metastasis duration of 17 months. Patients from rural areas and older subjects showed tendencies towards later diagnosis. The number of metastases varied, with nearly half presenting a single lesion.

Conclusions: COVID-19 pandemic-related disruptions in healthcare services led to delayed diagnosis and treatment of brain metastases, particularly impacting older and rural patients. These findings underscore the need for improved healthcare resilience and equitable access to oncological care to minimize delays and optimize outcomes during public health emergencies.

目的:评估2019冠状病毒病(COVID-19)大流行对乳腺癌继发性脑转移诊断和治疗延误的影响,并比较大流行前和期间的患者人口统计学、疾病特征和结局。材料和方法:对罗马尼亚Iasi临床急救医院“Prof. Dr. Nicolae Oblu”神经外科诊所接受脑转移手术治疗的100例患者进行回顾性研究。患者分为两组:大流行前(2018-2020年,n=57)和大流行期(2020-2022年,n=43)。收集和分析临床病理资料,包括人口统计学、转移定位、数量和持续时间。结果:大流行期间出现了向年轻患者的转变,51%的患者年龄小于55岁,而大流行前的平均年龄为57.9岁。转移灶多位于顶叶(61%)。尽管城乡患者分布平衡,但发现诊断延迟,平均转移持续时间为17个月。来自农村地区的患者和年龄较大的受试者有较晚诊断的倾向。转移的数量各不相同,近一半的人表现为单一病灶。结论:与COVID-19大流行相关的医疗服务中断导致脑转移的诊断和治疗延迟,特别是对老年和农村患者的影响。这些发现强调需要提高医疗韧性和公平获得肿瘤护理,以在突发公共卫生事件中最大限度地减少延误并优化结果。
{"title":"Impact of the COVID-19 Pandemic on Brain Metastases in Breast Cancer Patients.","authors":"Ruxandra Vatavu, Alexandru Misailoaie, Roxana Florentina Gavril, Codrin Gabriel Lucasievici, Anca Sava","doi":"10.26574/maedica.2025.20.2.250","DOIUrl":"10.26574/maedica.2025.20.2.250","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the impact of the COVID-19 pandemic on the diagnosis and treatment delays of brain metastases secondary to breast cancer, and to compare patient demographics, disease characteristics and outcomes before and during the pandemic.</p><p><strong>Materials and methods: </strong>A retrospective study was conducted on 100 patients who were surgically treated for brain metastases in the Neurosurgery Clinic of \"Prof. Dr. Nicolae Oblu\" Clinical Emergency Hospital, Iasi, Romania. Patients were divided into two groups: pre-pandemic (2018-2020, n=57) and pandemic (2020-2022, n=43). Clinicopathological data, including demographics, metastasis localization, number and duration, were collected and analyzed.</p><p><strong>Results: </strong>The pandemic period saw a shift towards younger patients, with 51% younger than 55 years compared to an average age of 57.9 years before the pandemic. Metastases were mostly located in the parietal lobe (61%). Despite a balanced rural-urban patient distribution, diagnostic delays were observed, with an average metastasis duration of 17 months. Patients from rural areas and older subjects showed tendencies towards later diagnosis. The number of metastases varied, with nearly half presenting a single lesion.</p><p><strong>Conclusions: </strong>COVID-19 pandemic-related disruptions in healthcare services led to delayed diagnosis and treatment of brain metastases, particularly impacting older and rural patients. These findings underscore the need for improved healthcare resilience and equitable access to oncological care to minimize delays and optimize outcomes during public health emergencies.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":"20 2","pages":"250-256"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12347055/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144981371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corneal Topography - a Review of Available Investigation Methods and Impact in the Diagnosis and Follow-Up of Keratoconus. 角膜地形学-圆锥角膜的现有调查方法及其对诊断和随访的影响。
Pub Date : 2025-06-01 DOI: 10.26574/maedica.2025.20.2.374
Maria-Silvia Dina, Maria-Cristina Marinescu, Catalina-Gabriela Corbu, Mihaela-Monica Constantin, Catalina-Ioana Tataru, Calin-Petru Tataru

Keratoconus is a bilateral non-inflammatory ectatic disease of the cornea, with an asymmetrical evolution, that occurs in young people during puberty, progressing during the second and third decades and stabilizing around the age of 40. It is characterised by an insidious and progressive thinning of the cornea, myopia and astigmatism, which lead to a decrease in visual acuity. Slit-lamp examination findings in the early stages of keratoconus may appear normal. However, in advanced stages of untreated keratoconus, visual acuity is diminished, which leads to a lower quality of life. Corneal topography is essential in the early diagnosis of the disease, analyzing the corneal geometry and thus helping to establish the method of treatment and to follow patients' evolution. This investigation combines the projection of a light source and a video capture system of corneal images with computer processing, providing maps of the distribution of dioptric power over the entire surface of the cornea. Topography can be classified into measuring the anterior surface of the cornea (keratometry and reflection-based topography) as well as both the anterior and posterior surfaces of the cornea (Scheimpflug slit-lamp scanning and pinhole optics). Understanding and reading corneal topographies is essential in correctly diagnosing and staging a keratoconus case. The present review constitutes a comprehensive evaluation of available methods and expected typical results and interpretation, in order to support clinicians in better managing this underdiagnosed ectasia affecting young patients.

圆锥角膜是一种双侧非炎症性角膜膨胀性疾病,具有不对称的演变,发生于青春期的年轻人,在第二和第三个十年期间进展,并在40岁左右稳定下来。它的特点是隐性的和渐进的角膜变薄,近视和散光,导致视力下降。裂隙灯检查的结果在圆锥角膜的早期阶段可能看起来正常。然而,在未经治疗的圆锥角膜晚期,视力下降,导致生活质量下降。角膜地形图在疾病的早期诊断中至关重要,分析角膜几何形状,从而帮助建立治疗方法并跟踪患者的发展。这项研究结合了光源投影和计算机处理的角膜图像视频捕捉系统,提供了整个角膜表面屈光功率分布的地图。地形学可分为测量角膜的前表面(角膜测量法和基于反射的地形学)以及测量角膜的前表面和后表面(Scheimpflug裂隙灯扫描和针孔光学)。了解和阅读角膜地形图对圆锥角膜的正确诊断和分期至关重要。本综述对现有的方法和预期的典型结果和解释进行了全面的评估,以支持临床医生更好地管理这种影响年轻患者的未被诊断的扩张。
{"title":"Corneal Topography - a Review of Available Investigation Methods and Impact in the Diagnosis and Follow-Up of Keratoconus.","authors":"Maria-Silvia Dina, Maria-Cristina Marinescu, Catalina-Gabriela Corbu, Mihaela-Monica Constantin, Catalina-Ioana Tataru, Calin-Petru Tataru","doi":"10.26574/maedica.2025.20.2.374","DOIUrl":"10.26574/maedica.2025.20.2.374","url":null,"abstract":"<p><p>Keratoconus is a bilateral non-inflammatory ectatic disease of the cornea, with an asymmetrical evolution, that occurs in young people during puberty, progressing during the second and third decades and stabilizing around the age of 40. It is characterised by an insidious and progressive thinning of the cornea, myopia and astigmatism, which lead to a decrease in visual acuity. Slit-lamp examination findings in the early stages of keratoconus may appear normal. However, in advanced stages of untreated keratoconus, visual acuity is diminished, which leads to a lower quality of life. Corneal topography is essential in the early diagnosis of the disease, analyzing the corneal geometry and thus helping to establish the method of treatment and to follow patients' evolution. This investigation combines the projection of a light source and a video capture system of corneal images with computer processing, providing maps of the distribution of dioptric power over the entire surface of the cornea. Topography can be classified into measuring the anterior surface of the cornea (keratometry and reflection-based topography) as well as both the anterior and posterior surfaces of the cornea (Scheimpflug slit-lamp scanning and pinhole optics). Understanding and reading corneal topographies is essential in correctly diagnosing and staging a keratoconus case. The present review constitutes a comprehensive evaluation of available methods and expected typical results and interpretation, in order to support clinicians in better managing this underdiagnosed ectasia affecting young patients.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":"20 2","pages":"374-382"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12347036/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144981460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pulmonary Plasmacytoma - Rare Occurrence in Multiple Myeloma: Case Presentation and Short Review of the Literature. 肺浆细胞瘤-罕见的多发性骨髓瘤:病例报告和简短的文献回顾。
Pub Date : 2025-06-01 DOI: 10.26574/maedica.2025.20.2.422
Daniela Diaconescu, Iuliana Iordan, Ion Dumitru, Ana-Maria Ilinescu, Delia Soare, Georgiana Ene, Horia Bumbea

Multiple myeloma is a hematological malignancy mostly diagnosed in the elderly. It is characterized by a chronic evolution with alternating periods of remission and relapses. Plasmacytoma, a tumor comprised of monoclonal plasma cells, is a typical finding in multiple myeloma patients, being more frequently observed during relapses. The most involved sites are bones, kidneys, liver, skin, ear, nose and throat. Extramedullary lung plasmacytomas are a rare presentation, with an incidence of well under 5% of all plasmacytomas. The clinical manifestations are heterogeneous and depend on the affected site. Differentiating plasmacytoma from other pathologies can be challenging, with the diagnosis being established via tumor biopsy. The presence of plasmacytoma is associated with poor prognosis and is a marker of rapid disease progression. We report the case of a 63-year-old patient diagnosed with IgA lambda multiple myeloma, stage IIIB Salmon-Durie complicated by lung plasmacytoma identified in the setting of relapse. Despite undergoing treatment, the disease exhibited an aggressive course, rapidly progressive towards death. The case underlines the rarity of pulmonary plasmacytoma and the diagnostic challenges.

多发性骨髓瘤是一种血液系统恶性肿瘤,多见于老年人。它的特点是慢性演变,交替出现缓解期和复发期。浆细胞瘤是一种由单克隆浆细胞组成的肿瘤,是多发性骨髓瘤患者的典型发现,在复发期间更常观察到。最受影响的部位是骨骼、肾脏、肝脏、皮肤、耳朵、鼻子和喉咙。髓外肺浆细胞瘤是一种罕见的表现,其发病率远低于所有浆细胞瘤的5%。临床表现是不同的,取决于受影响的部位。鉴别浆细胞瘤与其他病理是具有挑战性的,诊断是通过肿瘤活检建立。浆细胞瘤的存在与不良预后相关,是疾病快速进展的标志。我们报告一例63岁的IgA lambda多发性骨髓瘤患者,IIIB期沙门氏菌- durie并发复发的肺浆细胞瘤。尽管接受了治疗,该疾病仍表现出侵略性,迅速向死亡发展。该病例强调肺浆细胞瘤的罕见性和诊断上的挑战。
{"title":"Pulmonary Plasmacytoma - Rare Occurrence in Multiple Myeloma: Case Presentation and Short Review of the Literature.","authors":"Daniela Diaconescu, Iuliana Iordan, Ion Dumitru, Ana-Maria Ilinescu, Delia Soare, Georgiana Ene, Horia Bumbea","doi":"10.26574/maedica.2025.20.2.422","DOIUrl":"10.26574/maedica.2025.20.2.422","url":null,"abstract":"<p><p>Multiple myeloma is a hematological malignancy mostly diagnosed in the elderly. It is characterized by a chronic evolution with alternating periods of remission and relapses. Plasmacytoma, a tumor comprised of monoclonal plasma cells, is a typical finding in multiple myeloma patients, being more frequently observed during relapses. The most involved sites are bones, kidneys, liver, skin, ear, nose and throat. Extramedullary lung plasmacytomas are a rare presentation, with an incidence of well under 5% of all plasmacytomas. The clinical manifestations are heterogeneous and depend on the affected site. Differentiating plasmacytoma from other pathologies can be challenging, with the diagnosis being established via tumor biopsy. The presence of plasmacytoma is associated with poor prognosis and is a marker of rapid disease progression. We report the case of a 63-year-old patient diagnosed with IgA lambda multiple myeloma, stage IIIB Salmon-Durie complicated by lung plasmacytoma identified in the setting of relapse. Despite undergoing treatment, the disease exhibited an aggressive course, rapidly progressive towards death. The case underlines the rarity of pulmonary plasmacytoma and the diagnostic challenges.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":"20 2","pages":"422-427"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12347007/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144981417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Innovative Therapeutic Approaches in Systemic Mastocytosis: an Updated Review. 系统性肥大细胞增多症的创新治疗方法:最新综述。
Pub Date : 2025-06-01 DOI: 10.26574/maedica.2025.20.2.342
Delia Soare, Poliana Leru, Horia Bumbea

Introduction: Systemic mastocytosis (SM) is a heterogeneous clonal disorder characterized by the accumulation of abnormal mast cells in various tissues, predominantly the bone marrow. Given the rarity of the disease, the available data in Romania are extremely limited. It is estimated that the total number of diagnosed patients is approximately 170. In recent years, significant advances have been made in understanding the molecular pathogenesis of SM, leading to the development of targeted therapies that have transformed the management of this condition. The approval of tyrosine kinase inhibitors (TKIs), particularly midostaurin and avapritinib, has provided new therapeutic options for patients with advanced SM, demonstrating significant improvements in overall survival (OS) and symptom control.

Objective: To conduct a systematic review of clinical trials, observational studies and international or national guidelines published since 2000 to evaluate the efficacy, safety and mechanistic rationale of innovative therapeutic approaches for SM - including KIT inhibitors, monoclonal antibody-based therapies, stem cell transplant - and to compare the impact of these interventions with conventional cytoreductive and symptomatic treatments on overall response rate, survival, mediator-related symptom burden, quality of life and treatment-related adverse events.

Materials and methods: A comprehensive search was performed in MEDLINE ( via PubMed), Embase, the Cochrane Central Register of Controlled Trials and Web of Science from 1 January 2000 to 1 May 2025. ClinicalTrials.gov, WHO ICTRP. Search strings combined controlled vocabulary ( e.g. , "Mastocytosis") and free-text terms for the disease (systemic mastocytosis, advanced SM, indolent SM) with key innovative interventions (KIT inhibitors, avapritinib, midostaurin, monoclonal antibodies, stem cell transplant). No language limits were set at the search stage; non-English full texts were excluded only if an accurate translation could not be obtained. As the review relied exclusively on published or publicly available data, ethical approval and informed consent were not required.

Conclusion: The present review provides an updated overview of the evolving therapeutic landscape of SM, emphasizing recent clinical trial data, novel targeted therapies and emerging treatment paradigms. We discuss the implications of this progress on patient outcomes and future directions for personalized medicine in SM.

系统性肥大细胞增多症(SM)是一种异质性克隆性疾病,其特征是异常肥大细胞在各种组织中积聚,主要是骨髓。鉴于该病的罕见性,罗马尼亚现有的数据极为有限。据估计,确诊患者总数约为170人。近年来,在了解SM的分子发病机制方面取得了重大进展,导致靶向治疗的发展,改变了这种疾病的管理。酪氨酸激酶抑制剂(TKIs)的批准,特别是midoshuin和avapritinib,为晚期SM患者提供了新的治疗选择,显示出总生存期(OS)和症状控制的显着改善。摘要目的:对自2000年以来发表的临床试验、观察性研究和国际或国家指南进行系统回顾,以评估SM创新治疗方法的有效性、安全性和机制原理,包括KIT抑制剂、基于单克隆抗体的治疗、干细胞移植,并比较这些干预措施与传统的细胞减少和对症治疗对总缓解率、生存率的影响。中介剂相关症状负担、生活质量和治疗相关不良事件。材料和方法:从2000年1月1日至2025年5月1日,在MEDLINE(通过PubMed)、Embase、Cochrane Central Register of Controlled Trials和Web of Science进行了全面的检索。clinicaltrials。gov, WHO ICTRP。搜索字符串结合了控制词汇(如“肥大细胞增多症”)和疾病的自由文本术语(全身性肥大细胞增多症、晚期SM、惰性SM),以及关键的创新干预措施(KIT抑制剂、阿伐替尼、米多斯汀、单克隆抗体、干细胞移植)。在搜索阶段没有设置语言限制;只有在无法获得准确翻译的情况下,才排除非英文全文。由于审查完全依赖于已发表或公开可用的数据,因此不需要伦理批准和知情同意。结论:本综述提供了SM不断发展的治疗前景的最新概述,强调了最近的临床试验数据,新的靶向治疗和新兴的治疗范式。我们讨论了这一进展对SM患者预后的影响和个性化医疗的未来方向。
{"title":"Innovative Therapeutic Approaches in Systemic Mastocytosis: an Updated Review.","authors":"Delia Soare, Poliana Leru, Horia Bumbea","doi":"10.26574/maedica.2025.20.2.342","DOIUrl":"10.26574/maedica.2025.20.2.342","url":null,"abstract":"<p><strong>Introduction: </strong>Systemic mastocytosis (SM) is a heterogeneous clonal disorder characterized by the accumulation of abnormal mast cells in various tissues, predominantly the bone marrow. Given the rarity of the disease, the available data in Romania are extremely limited. It is estimated that the total number of diagnosed patients is approximately 170. In recent years, significant advances have been made in understanding the molecular pathogenesis of SM, leading to the development of targeted therapies that have transformed the management of this condition. The approval of tyrosine kinase inhibitors (TKIs), particularly midostaurin and avapritinib, has provided new therapeutic options for patients with advanced SM, demonstrating significant improvements in overall survival (OS) and symptom control.</p><p><strong>Objective: </strong>To conduct a systematic review of clinical trials, observational studies and international or national guidelines published since 2000 to evaluate the efficacy, safety and mechanistic rationale of innovative therapeutic approaches for SM - including KIT inhibitors, monoclonal antibody-based therapies, stem cell transplant - and to compare the impact of these interventions with conventional cytoreductive and symptomatic treatments on overall response rate, survival, mediator-related symptom burden, quality of life and treatment-related adverse events.</p><p><strong>Materials and methods: </strong>A comprehensive search was performed in MEDLINE ( via PubMed), Embase, the Cochrane Central Register of Controlled Trials and Web of Science from 1 January 2000 to 1 May 2025. ClinicalTrials.gov, WHO ICTRP. Search strings combined controlled vocabulary ( e.g. , \"Mastocytosis\") and free-text terms for the disease (systemic mastocytosis, advanced SM, indolent SM) with key innovative interventions (KIT inhibitors, avapritinib, midostaurin, monoclonal antibodies, stem cell transplant). No language limits were set at the search stage; non-English full texts were excluded only if an accurate translation could not be obtained. As the review relied exclusively on published or publicly available data, ethical approval and informed consent were not required.</p><p><strong>Conclusion: </strong>The present review provides an updated overview of the evolving therapeutic landscape of SM, emphasizing recent clinical trial data, novel targeted therapies and emerging treatment paradigms. We discuss the implications of this progress on patient outcomes and future directions for personalized medicine in SM.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":"20 2","pages":"342-352"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12347021/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144981443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Significance of Micrometastases and Isolated Tumor Cells in Breast Cancer. 乳腺癌微转移及分离肿瘤细胞的临床意义。
Pub Date : 2025-06-01 DOI: 10.26574/maedica.2025.20.2.353
Christos Ampatzis, Stefanos Zervoudis, Panagiotis Eskitzis, Panagiotis Tsikouras, Anthi Papakonstantinou, Georgios Iatrakis

We decided to do a literature search for information about the clinical significance of micrometastases (pN1mi) and isolated tumor cells (ITCs). A detailed search was conducted in the existing bibliography. We found that pN1mi and ITCs had differences in prognosis and were handled in a different way. However, some researchers do not accept this difference. Many studies have shown no differences in their prognosis and the distinction of these terms is questioned. This fact is attributed to different definitions, diagnostic approaches that have been used and not well organised research. For their diagnosis, single hematoxylin and eosin (H) stain slide section, and not routine immunohistochemical (IHC) stain, is recommended, despite a lot of institutions perform multiple level sections and IHC stains for each block of sentinel lymph nodes (SLNs). Once the limits within pN1mi and ITCs were defined, they have been based in small data, and here is an area where we should focus and build evidence based definitions that have proven differences and importance in clinical management. As for their therapy, in ITCs cases, axillary lymph node dissection (ALND) is omitted, but a large amount of data questions the safety of this omission. In pN1mi cases, ALND is performed.

我们决定对微转移(pN1mi)和分离肿瘤细胞(ITCs)的临床意义进行文献检索。在现有的参考书目中进行了详细的检索。我们发现pN1mi和ITCs在预后方面存在差异,处理方法也不同。然而,一些研究人员不接受这种差异。许多研究表明它们的预后没有差异,这些术语的区别受到质疑。这一事实归因于不同的定义、使用的诊断方法以及组织不完善的研究。对于他们的诊断,推荐使用单个苏木精和伊红(H)染色切片,而不是常规的免疫组化(IHC)染色,尽管许多机构对每个前哨淋巴结(sln)块进行多层切片和免疫组化染色。一旦确定了pN1mi和ITCs的限制,它们就建立在小数据的基础上,这是一个我们应该关注的领域,并建立基于证据的定义,这些定义在临床管理中已经证明了差异和重要性。在ITCs的治疗中,省略了腋窝淋巴结清扫术(axillary lymph node dissection, ALND),但大量的资料质疑这种省略的安全性。在pN1mi情况下,执行ALND。
{"title":"Clinical Significance of Micrometastases and Isolated Tumor Cells in Breast Cancer.","authors":"Christos Ampatzis, Stefanos Zervoudis, Panagiotis Eskitzis, Panagiotis Tsikouras, Anthi Papakonstantinou, Georgios Iatrakis","doi":"10.26574/maedica.2025.20.2.353","DOIUrl":"10.26574/maedica.2025.20.2.353","url":null,"abstract":"<p><p>We decided to do a literature search for information about the clinical significance of micrometastases (pN1mi) and isolated tumor cells (ITCs). A detailed search was conducted in the existing bibliography. We found that pN1mi and ITCs had differences in prognosis and were handled in a different way. However, some researchers do not accept this difference. Many studies have shown no differences in their prognosis and the distinction of these terms is questioned. This fact is attributed to different definitions, diagnostic approaches that have been used and not well organised research. For their diagnosis, single hematoxylin and eosin (H) stain slide section, and not routine immunohistochemical (IHC) stain, is recommended, despite a lot of institutions perform multiple level sections and IHC stains for each block of sentinel lymph nodes (SLNs). Once the limits within pN1mi and ITCs were defined, they have been based in small data, and here is an area where we should focus and build evidence based definitions that have proven differences and importance in clinical management. As for their therapy, in ITCs cases, axillary lymph node dissection (ALND) is omitted, but a large amount of data questions the safety of this omission. In pN1mi cases, ALND is performed.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":"20 2","pages":"353-357"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12347000/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144981390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Functional and Radiological Outcomes of Open Versus Arthroscopic Latarjet for Anterior Shoulder Instability. 开放与关节镜下Latarjet治疗前肩不稳的功能和放射学结果。
Pub Date : 2025-06-01 DOI: 10.26574/maedica.2025.20.2.289
Christos Koukos, Georgia Kanellopoulou, Dimitrios Giotis, Christos Yiannakopoulos, Stylianos Kapetanakis, Christos Konstantinidis, Saseendar Shanmugasundaram, Emilios E Pakos, Koray Sahin, Fredy Montoya

Objectives: The purpose of this study is to compare the clinical, functional and radiographic outcomes among 42 patients with anterior shoulder instability treated with either the open or arthroscopic Latarjet procedure.

Materials and methods: Between 2011 and 2018, we treated 42 patients with anterior shoulder instability, 19 underwent the open Latarjet procedure (OLP) and 23 underwent the arthroscopic Latarjet procedure (ALP). In the OLP group, 17 patients were males, with a mean age of 21.3 years (range: 16-37 years ) and a mean follow-up of 6.2 years (range: 5.5-7.2 years). In the ALP group, 20 patients were males, with a mean age of 20.6 years (range: 17-31 years) and a mean follow-up of 2.5 years (range: 2-3.1 years). All procedures were performed by a single surgeon. Functional outcomes were assessed using the University of California-Los Angeles (UCLA) shoulder score and the constant score (CS). Radiographic evaluations included standard radiographs and computed tomography (CT) scans. The two groups were compared to analyze differences in outcomes.

Results: All patients returned to their pre-injury level of activity. The arthroscopic Latarjet procedure resulted in better graft integration and inferior screw positioning. No major complications were reported in either group.

Conclusions: Anterior shoulder instability remains a complex issue in orthopedics regarding the optimal management approach. However, this study suggests that the arthroscopic Latarjet procedure offers advantages, including superior visualization and effective restoration of damage.

目的:本研究的目的是比较42例接受开放或关节镜下Latarjet手术治疗的肩关节前路不稳患者的临床、功能和影像学结果。材料和方法:在2011年至2018年期间,我们治疗了42例肩关节前部不稳定患者,其中19例接受了开放Latarjet手术(OLP), 23例接受了关节镜下Latarjet手术(ALP)。OLP组17例患者为男性,平均年龄21.3岁(范围16-37岁),平均随访6.2年(范围5.5-7.2年)。ALP组20例患者为男性,平均年龄20.6岁(17-31岁),平均随访2.5年(2-3.1年)。所有手术均由一名外科医生完成。功能结果采用加州大学洛杉矶分校(UCLA)肩部评分和恒定评分(CS)进行评估。影像学评估包括标准x线片和计算机断层扫描(CT)。对两组进行比较,分析结果的差异。结果:所有患者均恢复到损伤前的活动水平。关节镜下Latarjet手术使植骨融合更好,螺钉定位更低。两组均无重大并发症。结论:肩关节前路不稳在骨科中仍然是一个复杂的问题,需要考虑最佳的治疗方法。然而,本研究表明关节镜下Latarjet手术具有优势,包括优越的可视化和有效的损伤恢复。
{"title":"Functional and Radiological Outcomes of Open Versus Arthroscopic Latarjet for Anterior Shoulder Instability.","authors":"Christos Koukos, Georgia Kanellopoulou, Dimitrios Giotis, Christos Yiannakopoulos, Stylianos Kapetanakis, Christos Konstantinidis, Saseendar Shanmugasundaram, Emilios E Pakos, Koray Sahin, Fredy Montoya","doi":"10.26574/maedica.2025.20.2.289","DOIUrl":"10.26574/maedica.2025.20.2.289","url":null,"abstract":"<p><strong>Objectives: </strong>The purpose of this study is to compare the clinical, functional and radiographic outcomes among 42 patients with anterior shoulder instability treated with either the open or arthroscopic Latarjet procedure.</p><p><strong>Materials and methods: </strong>Between 2011 and 2018, we treated 42 patients with anterior shoulder instability, 19 underwent the open Latarjet procedure (OLP) and 23 underwent the arthroscopic Latarjet procedure (ALP). In the OLP group, 17 patients were males, with a mean age of 21.3 years (range: 16-37 years ) and a mean follow-up of 6.2 years (range: 5.5-7.2 years). In the ALP group, 20 patients were males, with a mean age of 20.6 years (range: 17-31 years) and a mean follow-up of 2.5 years (range: 2-3.1 years). All procedures were performed by a single surgeon. Functional outcomes were assessed using the University of California-Los Angeles (UCLA) shoulder score and the constant score (CS). Radiographic evaluations included standard radiographs and computed tomography (CT) scans. The two groups were compared to analyze differences in outcomes.</p><p><strong>Results: </strong>All patients returned to their pre-injury level of activity. The arthroscopic Latarjet procedure resulted in better graft integration and inferior screw positioning. No major complications were reported in either group.</p><p><strong>Conclusions: </strong>Anterior shoulder instability remains a complex issue in orthopedics regarding the optimal management approach. However, this study suggests that the arthroscopic Latarjet procedure offers advantages, including superior visualization and effective restoration of damage.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":"20 2","pages":"289-295"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12347057/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144981214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of Efficacy and Safety Profile of Vaginal Surgery and Hysteroscopic Electric Resection in the Management of Post-Cesarean Section Isthmocele: a Systematic Review. 阴道手术和宫腔镜电切治疗剖宫产术后峡部囊肿的疗效和安全性分析:系统综述。
Pub Date : 2025-06-01 DOI: 10.26574/maedica.2025.20.2.325
Manali Dande, Neha Lamba, Rashmi Bala Patel

Introduction: The present study has discussed the increasing prevalence of isthmocele, which is related to growing cesarean sections. It is also due to enhanced diagnostics, which includes transvaginal ultrasound (TVUS) and magnetic resonance imaging (MRI) that significantly affects women's reproductive health and quality of life. Management differs by defect size, from hysteroscopic to laparoscopic repair, which also highlights the necessity for standardized protocols.

Aim: s and objective: To evaluate the efficacy and safety profile of vaginal surgery and hysteroscopic electric resection in the management of post-cesarean section isthmocele.

Methods: This systematic review analyzed the efficacy and safety of vaginal surgery and hysteroscopic electrotomy for managing post-cesarean section isthmocele. Relevant studies were identified from PubMed, Embase, Cochrane Library and Web of Science using terms like "cesarean scar", "isthmocele" and "hysteroscopic electrotomy". We conducted the present review using a PRISMA flowchart, which resulted in the inclusion of eight studies after screening and eligibility assessment.

Results: The hysteroscopic method consistently shows a lower risk compared to the vaginal method, with a pooled risk ratio of 0.71 (95% CI 0.59-0.85), indicating statistical significance. Heterogeneity analysis reveals no significant variability among studies (I² = 0%), suggesting consistent results. Additionally, the hysteroscopic group outperforms the vaginal group in efficacy for diverticulum recovery, supporting hysteroscopy as the more effective approach across both outcomes.

Conclusion: The present study has concluded that the hysteroscopic electric resection was safer and more efficient in the management of isthmocele among patients who underwent a cesarean section.

前言:本研究讨论了峡部膨出的日益流行,这与剖宫产率的增加有关。这也是由于经阴道超声(TVUS)和磁共振成像(MRI)等诊断方法的改进,它们对妇女的生殖健康和生活质量产生了重大影响。从宫腔镜到腹腔镜修复,治疗方法因缺陷大小而异,这也强调了标准化治疗方案的必要性。目的和目的:评价阴道手术联合宫腔镜电切治疗剖宫产术后峡部膨出的疗效和安全性。方法:本系统综述分析阴道手术和宫腔镜下电切术治疗剖宫产术后峡部囊肿的疗效和安全性。相关研究从PubMed、Embase、Cochrane Library和Web of Science中检索,使用“剖宫产疤痕”、“峡部囊肿”和“宫腔镜电切术”等术语。我们使用PRISMA流程图进行了本综述,在筛选和资格评估后纳入了8项研究。结果:宫腔镜方法的风险始终低于阴道方法,合并风险比为0.71 (95% CI 0.59 ~ 0.85),差异有统计学意义。异质性分析显示各研究间无显著差异(I²= 0%),提示结果一致。此外,宫腔镜组在憩室恢复的疗效上优于阴道组,支持宫腔镜在两种结果中都是更有效的方法。结论:本研究认为宫腔镜电切术治疗剖宫产患者峡部膨出更安全、有效。
{"title":"Analysis of Efficacy and Safety Profile of Vaginal Surgery and Hysteroscopic Electric Resection in the Management of Post-Cesarean Section Isthmocele: a Systematic Review.","authors":"Manali Dande, Neha Lamba, Rashmi Bala Patel","doi":"10.26574/maedica.2025.20.2.325","DOIUrl":"10.26574/maedica.2025.20.2.325","url":null,"abstract":"<p><strong>Introduction: </strong>The present study has discussed the increasing prevalence of isthmocele, which is related to growing cesarean sections. It is also due to enhanced diagnostics, which includes transvaginal ultrasound (TVUS) and magnetic resonance imaging (MRI) that significantly affects women's reproductive health and quality of life. Management differs by defect size, from hysteroscopic to laparoscopic repair, which also highlights the necessity for standardized protocols.</p><p><strong>Aim: </strong>s and objective: To evaluate the efficacy and safety profile of vaginal surgery and hysteroscopic electric resection in the management of post-cesarean section isthmocele.</p><p><strong>Methods: </strong>This systematic review analyzed the efficacy and safety of vaginal surgery and hysteroscopic electrotomy for managing post-cesarean section isthmocele. Relevant studies were identified from PubMed, Embase, Cochrane Library and Web of Science using terms like \"cesarean scar\", \"isthmocele\" and \"hysteroscopic electrotomy\". We conducted the present review using a PRISMA flowchart, which resulted in the inclusion of eight studies after screening and eligibility assessment.</p><p><strong>Results: </strong>The hysteroscopic method consistently shows a lower risk compared to the vaginal method, with a pooled risk ratio of 0.71 (95% CI 0.59-0.85), indicating statistical significance. Heterogeneity analysis reveals no significant variability among studies (I² = 0%), suggesting consistent results. Additionally, the hysteroscopic group outperforms the vaginal group in efficacy for diverticulum recovery, supporting hysteroscopy as the more effective approach across both outcomes.</p><p><strong>Conclusion: </strong>The present study has concluded that the hysteroscopic electric resection was safer and more efficient in the management of isthmocele among patients who underwent a cesarean section.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":"20 2","pages":"325-333"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12347009/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144981441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disruptions in Renal Stone Management during the COVID-19 Pandemic: a Retrospective Single-Center Study. COVID-19大流行期间肾结石管理中断:一项回顾性单中心研究
Pub Date : 2025-06-01 DOI: 10.26574/maedica.2025.20.2.243
Adrian Militaru, Catalin Andrei Bulai, Razvan Dragos Multescu, Cosmin Victor Ene, Mihai Andrei Ene, Cristian Mares, Stefan Balacescu, Dragos Adrian Georgescu, Petrisor Aurelian Geavlete, Bogdan Florin Geavlete

Objectives: This study evaluated changes in renal stone management during the COVID-19 pandemic in a single center, focusing on treatment methods, patient outcomes and healthcare delivery models.

Materials and methods: We conducted a retrospective analysis comparing patients treated for kidney stones between July-September 2019 (pre-pandemic period) and July-September 2020 (pandemic period). We assessed the number of treated patients, treatment modalities and postoperative outcomes.

Results: A total of 77 inpatients were analyzed, of whom 50 had been admitted to hospital during the pre-pandemic period and 27 during the pandemic, which represented a 46% decrease in hospitalizations. There were no significant differences in body mass index, average age, stone laterality, size, or location. Serum creatinine levels and positive urine cultures were also comparable between the groups. A trend toward more minimally invasive procedures was observed during the pandemic, with an increased use of flexible ureteroscopy (62% vs . 70.4%) and a decrease in percutaneous nephrolithotomy (12% vs . 7.4%). Operative times and hospital stays were similar across groups. However, the stone-free rate significantly decreased during the pandemic (91.1% vs . 84.07%).

Conclusions: The COVID-19 pandemic significantly disrupted renal stone management, leading to a preference for minimally invasive surgery but a lower stone-free rate.

目的:本研究在单一中心评估了COVID-19大流行期间肾结石管理的变化,重点关注治疗方法、患者结局和医疗保健服务模式。材料和方法:我们对2019年7月至9月(大流行前)和2020年7月至9月(大流行期间)接受肾结石治疗的患者进行了回顾性分析。我们评估了治疗患者的数量、治疗方式和术后结果。结果:共分析了77名住院患者,其中50人在大流行前住院,27人在大流行期间住院,住院率下降了46%。两组在体重指数、平均年龄、结石偏侧、大小或位置方面无显著差异。血清肌酐水平和阳性尿培养在两组之间也具有可比性。在大流行期间,观察到微创手术的趋势,输尿管软镜的使用增加(62%对62%)。70.4%)和经皮肾镜取石术的减少(12% vs。7.4%)。各组手术时间和住院时间相似。然而,在大流行期间,无结石率显著下降(91.1% vs . 91.1%)。84.07%)。结论:2019冠状病毒病大流行显著破坏了肾结石的治疗,导致首选微创手术,但肾结石无结石率较低。
{"title":"Disruptions in Renal Stone Management during the COVID-19 Pandemic: a Retrospective Single-Center Study.","authors":"Adrian Militaru, Catalin Andrei Bulai, Razvan Dragos Multescu, Cosmin Victor Ene, Mihai Andrei Ene, Cristian Mares, Stefan Balacescu, Dragos Adrian Georgescu, Petrisor Aurelian Geavlete, Bogdan Florin Geavlete","doi":"10.26574/maedica.2025.20.2.243","DOIUrl":"10.26574/maedica.2025.20.2.243","url":null,"abstract":"<p><strong>Objectives: </strong>This study evaluated changes in renal stone management during the COVID-19 pandemic in a single center, focusing on treatment methods, patient outcomes and healthcare delivery models.</p><p><strong>Materials and methods: </strong>We conducted a retrospective analysis comparing patients treated for kidney stones between July-September 2019 (pre-pandemic period) and July-September 2020 (pandemic period). We assessed the number of treated patients, treatment modalities and postoperative outcomes.</p><p><strong>Results: </strong>A total of 77 inpatients were analyzed, of whom 50 had been admitted to hospital during the pre-pandemic period and 27 during the pandemic, which represented a 46% decrease in hospitalizations. There were no significant differences in body mass index, average age, stone laterality, size, or location. Serum creatinine levels and positive urine cultures were also comparable between the groups. A trend toward more minimally invasive procedures was observed during the pandemic, with an increased use of flexible ureteroscopy (62% vs . 70.4%) and a decrease in percutaneous nephrolithotomy (12% vs . 7.4%). Operative times and hospital stays were similar across groups. However, the stone-free rate significantly decreased during the pandemic (91.1% vs . 84.07%).</p><p><strong>Conclusions: </strong>The COVID-19 pandemic significantly disrupted renal stone management, leading to a preference for minimally invasive surgery but a lower stone-free rate.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":"20 2","pages":"243-249"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12347054/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144981467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the Complications and Risk of Urosepsis after Flexible Ureteroscopy in a Sodium-Glucose Co-transporter-2 Inhibitor Population with Heart Failure with Reduced Ejection Fraction. 评估钠-葡萄糖共转运蛋白-2抑制剂心力衰竭伴射血分数降低患者输尿管软镜术后尿脓毒症的并发症和风险
Pub Date : 2025-06-01 DOI: 10.26574/maedica.2025.20.2.235
Madalina Andreea Munteanu, Camelia Nicolae, George Dragomiristeanu, Anca Lungu, Irina Andrei, Dorin Ionita, Mihai-Catalin Cacoveanu, Alice-Elena Munteanu, Tiberiu Ioan Nanea
<p><strong>Introduction: </strong>Recent guidelines highlight the significant role of sodium-glucose co-transporter-2 inhibitors (SGLT2is) in enhancing the overall condition of patients with heart failure with reduced ejection fraction (HFrEF), leading to their widespread use, but recent studies revealed an increased prevalence of urinary tract infections (UTIs) associated with this medication. The aim of the present study is to evaluate the risk of urosepsis after flexible ureteroscopy with flexible navigable vacuum assisted access sheath in patients diagnosed with renal stone disease who are using SGLT2i for HFrEF.</p><p><strong>Materials and methods: </strong>This prospective comparative study included patients who were taking a SGLT2i (dapagliflozin 10 mg per day or empagliflozin 10 mg per day) for HFrEF and underwent flexible ureteroscopy in "Prof. Dr. Theodor Burghele" Clinical Hospital, Bucharest, Romania, between 01.01.2021 and 31.12.2024 for renal stone disease. All patients were completely assessed via imaging exam, complete blood count and urine analysis. The inclusion criteria were as follows: patients over 18 years old, established documented diagnosis of symptomatic HFrEF (Heart Failure New York Heart Association functional class II-IV), which has been present for at least two months and was optimally treated with pharmacological and/or device therapy, administration of SGLT2i, single-use flexible ureteroscopy, flexible and navigable vacuum-assisted ureteral access sheath (UAS) and the largest stone diameter less than 2 cm. The surgical technique met the same standard according to the recent recommendations of the International Alliance of Urolithiasis guideline on retrograde intrarenal surgery.</p><p><strong>Results: </strong>Seventy-three patients who met the inclusion criteria were divided into two groups, according to previous SGLT2i administration, as follows: Group 1 (patients with SGLT2i) and Group 2 ( non-SGLT2i patients ). After analysing the demographic data, a slightly increased prevalence in female subjects was observed. There were no statistically different results regarding important pre-surgical data, such as mean stone dimension or density (HU), but there were preoperative differences regarding the prevalence of UTIs. After analyzing perioperative parameters such as mean previous JJ stented patients, mean surgical time and mean fluoroscopy time, the findings revealed no statistically significant differences. Regarding the main objective of the study, the present results revealed no differences in overall postoperative complications. There was a small number of postoperative urinary sepsis cases: three patients in Group 1 and two patients in Group 2.</p><p><strong>Conclusion: </strong>Although SGLT2i administration may even increase the risk of developing UTIs, this does not influence the postoperative complications outcome after flexible ureteroscopy for renal stone disease. High-standard equipment such as single-use
导读:最近的指南强调了钠-葡萄糖共转运蛋白-2抑制剂(SGLT2is)在改善心力衰竭伴射血分数降低(HFrEF)患者的整体状况方面的重要作用,导致其广泛使用,但最近的研究显示与该药物相关的尿路感染(uti)患病率增加。本研究的目的是评估诊断为肾结石疾病且使用SGLT2i治疗HFrEF的患者在柔性可导航真空辅助输尿管鞘输尿管镜检查后尿脓毒症的风险。材料和方法:本前瞻性比较研究纳入了于2021年1月1日至2024年12月31日期间在罗马尼亚布加勒斯特“教授博士Theodor Burghele”临床医院接受SGLT2i(达格列净10mg /天或恩格列净10mg /天)治疗HFrEF并行输尿管软镜检查的肾结石患者。所有患者均通过影像学检查、全血细胞计数和尿液分析进行全面评估。纳入标准如下:患者年龄大于18岁,确诊为症状性HFrEF(心衰纽约心脏协会功能分类II-IV),存在至少两个月,最佳治疗方法为药物和/或器械治疗,给予SGLT2i,一次性柔性输尿管镜检查,柔性和可导航的真空辅助输尿管通道鞘(UAS),最大结石直径小于2cm。根据国际尿石症联盟关于逆行肾内手术指南的最新建议,手术技术符合相同的标准。结果:73例符合纳入标准的患者根据既往SGLT2i给药情况分为两组:1组(SGLT2i患者)和2组(非SGLT2i患者)。在分析人口统计数据后,观察到女性受试者的患病率略有增加。在重要的术前数据方面,如平均结石尺寸或密度(HU),结果无统计学差异,但在尿路感染的患病率方面存在术前差异。通过对既往JJ支架平均患者、平均手术时间、平均透视时间等围手术期参数的分析,发现两组间无统计学差异。关于本研究的主要目的,目前的结果显示在总体术后并发症方面没有差异。术后尿脓毒症病例较少,1组3例,2组2例。结论:尽管SGLT2i给药甚至可能增加发生尿路感染的风险,但这并不影响肾结石柔性输尿管镜术后并发症的结局。高标准的设备,如一次性使用的装置和输尿管吸入套,即使在尿路感染中发生败血症也具有安全的特点,方便了药物管理。
{"title":"Evaluating the Complications and Risk of Urosepsis after Flexible Ureteroscopy in a Sodium-Glucose Co-transporter-2 Inhibitor Population with Heart Failure with Reduced Ejection Fraction.","authors":"Madalina Andreea Munteanu, Camelia Nicolae, George Dragomiristeanu, Anca Lungu, Irina Andrei, Dorin Ionita, Mihai-Catalin Cacoveanu, Alice-Elena Munteanu, Tiberiu Ioan Nanea","doi":"10.26574/maedica.2025.20.2.235","DOIUrl":"10.26574/maedica.2025.20.2.235","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Recent guidelines highlight the significant role of sodium-glucose co-transporter-2 inhibitors (SGLT2is) in enhancing the overall condition of patients with heart failure with reduced ejection fraction (HFrEF), leading to their widespread use, but recent studies revealed an increased prevalence of urinary tract infections (UTIs) associated with this medication. The aim of the present study is to evaluate the risk of urosepsis after flexible ureteroscopy with flexible navigable vacuum assisted access sheath in patients diagnosed with renal stone disease who are using SGLT2i for HFrEF.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Materials and methods: &lt;/strong&gt;This prospective comparative study included patients who were taking a SGLT2i (dapagliflozin 10 mg per day or empagliflozin 10 mg per day) for HFrEF and underwent flexible ureteroscopy in \"Prof. Dr. Theodor Burghele\" Clinical Hospital, Bucharest, Romania, between 01.01.2021 and 31.12.2024 for renal stone disease. All patients were completely assessed via imaging exam, complete blood count and urine analysis. The inclusion criteria were as follows: patients over 18 years old, established documented diagnosis of symptomatic HFrEF (Heart Failure New York Heart Association functional class II-IV), which has been present for at least two months and was optimally treated with pharmacological and/or device therapy, administration of SGLT2i, single-use flexible ureteroscopy, flexible and navigable vacuum-assisted ureteral access sheath (UAS) and the largest stone diameter less than 2 cm. The surgical technique met the same standard according to the recent recommendations of the International Alliance of Urolithiasis guideline on retrograde intrarenal surgery.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Seventy-three patients who met the inclusion criteria were divided into two groups, according to previous SGLT2i administration, as follows: Group 1 (patients with SGLT2i) and Group 2 ( non-SGLT2i patients ). After analysing the demographic data, a slightly increased prevalence in female subjects was observed. There were no statistically different results regarding important pre-surgical data, such as mean stone dimension or density (HU), but there were preoperative differences regarding the prevalence of UTIs. After analyzing perioperative parameters such as mean previous JJ stented patients, mean surgical time and mean fluoroscopy time, the findings revealed no statistically significant differences. Regarding the main objective of the study, the present results revealed no differences in overall postoperative complications. There was a small number of postoperative urinary sepsis cases: three patients in Group 1 and two patients in Group 2.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Although SGLT2i administration may even increase the risk of developing UTIs, this does not influence the postoperative complications outcome after flexible ureteroscopy for renal stone disease. High-standard equipment such as single-use","PeriodicalId":74094,"journal":{"name":"Maedica","volume":"20 2","pages":"235-242"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12376533/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144981477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Cognitive Functions among Bilinguals and Multilinguals. 双语者与多语者认知功能的比较。
Pub Date : 2025-06-01 DOI: 10.26574/maedica.2025.20.2.310
Medala Kalpana, Roja Katta, Patil Umesh Parag, Saikrishna Tikka, Umesh Madhusudhan, Archana Gaur, Vidya Ganji, Madhuri Taranikanti, Nitin Ashok John, Vasanthkumar Kasturi

Background: Language is one of the most fundamental aspects of any society. It is how individuals communicate with one another, form relationships and foster a feeling of community. Language processing is one of the most common, yet complex, tasks we perform regularly. Being multilingual facilitates effective communication and such people are better problem solvers. The benefits of multilingualism extend beyond the capacity to communicate in another language and provide individuals with a broader perspective of the world. This study aims to assess the cognitive functions of bilinguals and multilinguals and to compare the cognitive functions among bilingual and multilingual individuals.

Materials and methods: Nearly 115 members were screened for anemia, thyroid abnormalities, diabetes mellitus and other electrolyte imbalances to select the study participants in the age group of 30-50 years. Strub black mental status test was used for reading and writing, and controlled word association test for fluency. Depending on these observations, participants were divided into monolinguals, bilinguals, trilinguals and multilinguals. Stroop test was used to assess the cognitive function.

Results: Mean scores and reaction time for color-to-word tests among monolingual and multilingual were 7.7±1.99, 21.65±3.68 and 9.9±0.29, 16.44±1.81, respectively. Mean scores and reaction time for word-to-color tests among monolinguals and multilinguals were and 7.65±1.12, 23.61±3.69 and 9.7±0.696, 13.80±3.14, respectively.

Conclusion: Inculcating multiple languages at a younger age might enhance cognitive skills and overall effectiveness.

背景:语言是任何社会最基本的方面之一。它是个体如何与他人沟通,建立关系和培养社区感觉。语言处理是我们经常执行的最常见但也最复杂的任务之一。掌握多种语言有助于有效的沟通,这些人是更好的问题解决者。使用多种语言的好处不仅在于能够用另一种语言进行交流,还在于为个人提供了更广阔的世界观。本研究旨在评估双语者和多语者的认知功能,并比较双语者和多语者的认知功能。材料与方法:选取年龄在30-50岁之间的研究对象,对近115名成员进行贫血、甲状腺异常、糖尿病等电解质失衡筛查。阅读和写作采用斯特鲁布黑人心理状态测试,流畅性采用对照词联想测试。根据这些观察,参与者被分为单语者、双语者、三语者和多语者。采用Stroop测验评估认知功能。结果:单语组和多语组的色字测试平均得分分别为7.7±1.99、21.65±3.68分和9.9±0.29、16.44±1.81分。单语组和多语组的平均反应时间分别为7.65±1.12、23.61±3.69和9.7±0.696、13.80±3.14。结论:在幼儿时期进行多语言教育可以提高认知能力和整体效能。
{"title":"Comparison of Cognitive Functions among Bilinguals and Multilinguals.","authors":"Medala Kalpana, Roja Katta, Patil Umesh Parag, Saikrishna Tikka, Umesh Madhusudhan, Archana Gaur, Vidya Ganji, Madhuri Taranikanti, Nitin Ashok John, Vasanthkumar Kasturi","doi":"10.26574/maedica.2025.20.2.310","DOIUrl":"10.26574/maedica.2025.20.2.310","url":null,"abstract":"<p><strong>Background: </strong>Language is one of the most fundamental aspects of any society. It is how individuals communicate with one another, form relationships and foster a feeling of community. Language processing is one of the most common, yet complex, tasks we perform regularly. Being multilingual facilitates effective communication and such people are better problem solvers. The benefits of multilingualism extend beyond the capacity to communicate in another language and provide individuals with a broader perspective of the world. This study aims to assess the cognitive functions of bilinguals and multilinguals and to compare the cognitive functions among bilingual and multilingual individuals.</p><p><strong>Materials and methods: </strong>Nearly 115 members were screened for anemia, thyroid abnormalities, diabetes mellitus and other electrolyte imbalances to select the study participants in the age group of 30-50 years. Strub black mental status test was used for reading and writing, and controlled word association test for fluency. Depending on these observations, participants were divided into monolinguals, bilinguals, trilinguals and multilinguals. Stroop test was used to assess the cognitive function.</p><p><strong>Results: </strong>Mean scores and reaction time for color-to-word tests among monolingual and multilingual were 7.7±1.99, 21.65±3.68 and 9.9±0.29, 16.44±1.81, respectively. Mean scores and reaction time for word-to-color tests among monolinguals and multilinguals were and 7.65±1.12, 23.61±3.69 and 9.7±0.696, 13.80±3.14, respectively.</p><p><strong>Conclusion: </strong>Inculcating multiple languages at a younger age might enhance cognitive skills and overall effectiveness.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":"20 2","pages":"310-315"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12346999/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144981499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Maedica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1